Table: Hisamitsu -2025/26 parent results
Apr 13 (Reuters)-
Hisamitsu Pharmaceutical Co Inc
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to NEXT
Feb 28, 2026 Feb 28, 2025 Feb 28, 2027 YEAR
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULTS FORECAST H1 FORECAST
Sales 103.76 102.62
(+1.1 pct) (+6.2 pct)
Operating 7.44 13.71
(-45.8 pct) (+28.1 pct)
Recurring 11.29 16.51
(-31.6 pct) (+16.1 pct)
Net 9.25 16.36
(-43.5 pct) (+66.0 pct)
EPS 129.55 yen 222.20 yen
EPS Diluted 129.39 yen 221.88 yen
Ann Div 60.00 yen 90.00 yen
-Q2 Div 60.00 yen 45.00 yen
-Q4 Div NIL 45.00 yen
NOTE - Hisamitsu Pharmaceutical Co Inc.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4530.T
Recent news on Hisamitsu Pharmaceutical Co
See all newsTable: Hisamitsu -2025/26 group results
Table: Hisamitsu -2025/26 parent results
Brief: Hisamitsu Pharmaceutical Co Inc - To Retire Treasury Shares Worth 6.34% Of Outstanding Stock On May 12
Brief: Hisamitsu Pharmaceutical Co Inc - Tender Offer Of Company By Taiyo Kosan Successfully Completed
Japan's Hisamitsu Pharmaceutical plans $2.55 billion MBO